1. Home
  2. PRQR vs ONCH Comparison

PRQR vs ONCH Comparison

Compare PRQR & ONCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.81

Market Cap

166.4M

Sector

Health Care

ML Signal

HOLD

ONCH

1RT Acquisition Corp. Class A Ordinary Share

N/A

Current Price

$10.17

Market Cap

220.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PRQR
ONCH
Founded
2012
2024
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
166.4M
220.2M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
PRQR
ONCH
Price
$1.81
$10.17
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$7.67
N/A
AVG Volume (30 Days)
306.7K
110.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$18.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.08
$10.16
52 Week High
$3.10
$10.63

Technical Indicators

Market Signals
Indicator
PRQR
ONCH
Relative Strength Index (RSI) 58.41 39.29
Support Level $1.65 $10.17
Resistance Level $2.27 $10.26
Average True Range (ATR) 0.10 0.02
MACD 0.05 -0.00
Stochastic Oscillator 66.67 11.11

Price Performance

Historical Comparison
PRQR
ONCH

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About ONCH 1RT Acquisition Corp. Class A Ordinary Share

1RT Acquisition Corp is a blank check company.

Share on Social Networks: